This topic contains a solution. Click here to go to the answer

Author Question: For a multiple-baseline design to demonstrate treatment effectiveness, a. all target behaviors ... (Read 39 times)

pepyto

  • Hero Member
  • *****
  • Posts: 547
For a multiple-baseline design to demonstrate treatment effectiveness,
 
  a. all target behaviors should change, but only after the treatment is imposed for each one.
  b. all target behaviors should change when the first treatment is imposed.
  c. some target behaviors should increase in frequency with the treatment and others should decrease.
  d. treated behaviors should change from baseline immediately while untreated behaviors should change more slowly.

Question 2

Which of the following is a national organization for psychologists?
 
  a. American Psychological Association
  b. Association for Psychological Science
  c. Association for Psychological Research
  d. A and B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shaikhs

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

A

Answer to Question 2

D




pepyto

  • Member
  • Posts: 547
Reply 2 on: Jul 13, 2018
Wow, this really help


bimper21

  • Member
  • Posts: 309
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

For a complete list of videos, visit our video library